Free shipping on all orders over $ 500

Emtricitabine

Cat. No. M3342

All AbMole products are for research use only, cannot be used for human consumption.

Emtricitabine Structure
Synonym:

BW1592

Size Price Availability Quantity
Free Sample (1-2 mg)  USD 0 In stock
25mg USD 25  USD25 In stock
50mg USD 40  USD40 In stock
100mg USD 60  USD60 In stock
500mg USD 90  USD90 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Emtricitabine (Emtriva) is a nucleoside reverse transcriptase inhibitor with an IC50 of 27.7 μM.The compound works by inhibiting reverse transcriptase, the enzyme that copies HIV RNA into new viral DNA. By interfering with this process, which is central to the replication of HIV, emtricitabine can help to lower the amount of HIV, or "viral load", in a patient’s body and can indirectly increase the number of immune system cells (called T cells or CD4+ T-cells). Both of these changes are associated with healthier immune systems and decreased likelihood of serious illness.

Chemical Information
Molecular Weight 247.25
Formula C8H10FN3O3S
CAS Number 143491-57-0
Solubility (25°C) DMSO 60 mg/mL
Water 15 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Onyema Ogbuagu, et al. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

[2] Kenneth H Mayer, et al. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

[3] Paul E Sax, et al. Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus

[4] Abdulrahman A Al-Majed, et al. Emtricitabine

[5] Emma D Deeks. Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection

Related Reverse Transcriptase Products
Tenofovir diphosphate

Tenofovir diphosphate (TFV-DP) is a competitive DNA polymerases inhibitor (with respect to dATP) and a substrate of HIV type 1 (HIV-1) reverse transcriptase (RT).

Tenofovir diphosphate triethylamine

Tenofovir diphosphate triethylamine (TFV-DP triethylamine) is a competitive DNA polymerases inhibitor (with respect to dATP) and a substrate of HIV type 1 (HIV-1) reverse transcriptase (RT).

Fosalvudine tidoxil

Fosalvudine tidoxil is an orally active nucleoside reverse transcriptase inhibitor (NRTI).

Emtricitabine triphosphate tetrasodium salt

Emtricitabine triphosphate tetrasodium salt is the tetrasodium salt form of Emtricitabine triphosphate and a nucleoside reverse transcriptase inhibitor (NRTI) targeting HIV and HBV.

M-MLV Reverse transcriptase

M-MLV Reverse transcriptase (M-MLV RT) is a kind of Reverse transcriptase, from the moroni mouse leukemia virus (MoMLV).

  Catalog
Abmole Inhibitor Catalog




Keywords: Emtricitabine, BW1592 supplier, Reverse Transcriptase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.